A-share Lightning protection on July 15 | Tailin Bio: Gao De Investment intends to reduce its shareholding by no more than 1.67%; Chipbond Technology: expects to lose 0.439 billion yuan in the first half of the year.
Boji Medical Technology's controlling shareholder, the concerted action person, intends to reduce its shareholding by no more than 1.5%. Tailin Bio's shareholder, Gaode Investment, intends to reduce its shareholding by no more than 1.67%. Xilinx expects to lose 0.439 billion yuan in the first half of the year. Greentown Technology stated that the U.S. Commerce Department has initiated an anti-dumping and countervailing investigation into certain low-speed vehicles imported from China.
Tailin Biotech (300813.SZ) plans to pay 1 yuan for 10 shares to be deducted from interest on May 27
Tailin Biotech (300813.SZ) announced that the company's 2023 equity distribution plan: every 10 shares to all shareholders...
Optimistic Investors Push Zhejiang Tailin BioEngineering Co.,Ltd (SZSE:300813) Shares Up 42% But Growth Is Lacking
Zhejiang Tailin BioEngineering Co.,Ltd (SZSE:300813) shares have continued their recent momentum with a 42% gain in the last month alone. Longer-term shareholders would be thankful for the recovery
Tailin Biotech (300813.SZ): The subsidiary has no products in the manufacture of bio-based materials or synthetic materials
Gelonghui, May 9丨Tailin Biology (300813.SZ) said on the investor interactive platform that its subsidiary Tailin Medical Devices currently has no products in the manufacture of bio-based materials or synthetic materials.
Tailin Biotech (300813.SZ): The company has no medical equipment related to autologous stem cell regeneration insulin transplantation
Gelonghui, May 9丨Tailin Biotech (300813.SZ) said on the investor interactive platform that the company has no medical equipment related to autologous stem cell regeneration insulin transplantation.
Tailin Biology (300813.SZ): Currently, there is no direct layout in the direction of synthetic biology
On May 7, Gelonghui | Tailin Biotech (300813.SZ) said on the investor interactive platform that the company currently has no direct layout in the direction of synthetic biology.
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Tailin BioEngineeringLtd (SZSE:300813)
Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) stock showed strength, with investors undeterred by its weak earnings report. We think that shareholders might be missing some concerning factor
Optimistic Investors Push Zhejiang Tailin BioEngineering Co.,Ltd (SZSE:300813) Shares Up 28% But Growth Is Lacking
Zhejiang Tailin BioEngineering Co.,Ltd (SZSE:300813) shareholders are no doubt pleased to see that the share price has bounced 28% in the last month, although it is still struggling to make up recentl
Tailin Biotech (300813.SZ): 2023 net profit pre-reduced by 66.12%-77.41%
Gelonghui, January 30, 丨 Tailin Biotech (300813.SZ) announced its 2023 annual results forecast. Net profit attributable to shareholders of listed companies during the reporting period was 18 million yuan to 27 million yuan, down 77.41%-66.12% from the same period last year; net profit profit after deducting non-recurring profit and loss was 11 million yuan to 16.5 million yuan, down 84.87%-77.31% from the same period last year. The main reasons why the company's net profit attributable to shareholders of listed companies declined in the same direction during the reporting period compared to the previous year: 1. During the reporting period, the inspection period required by some customers was extended
Subdued Growth No Barrier To Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Price
With a price-to-earnings (or "P/E") ratio of 40.6x Zhejiang Tailin BioEngineering Co.,Ltd (SZSE:300813) may be sending bearish signals at the moment, given that almost half of all companies in China h
Tailin Biotech (300813.SZ) subsidiary plans to invest 10 million yuan in Hongzhong Baide to cultivate new business growth points
Tailin Biotech (300813.SZ) announced that Zhejiang Tailin Life Science Co., Ltd., a wholly-owned subsidiary of the company (abbreviation “...
Tailin Biotech (300813.SZ): Proposes to establish a joint venture to carry out business related to cell testing, cell drugs, intelligent microbial testing, etc.
Gelonghui, January 2, 丨 Tailin Biology (300813.SZ) announced that on December 28, 2023, Zhejiang Tailin Biotechnology Co., Ltd. and Keyida Biotechnology (Hangzhou) Co., Ltd. (“Keyida”), a partnership (limited partnership) of Kezhda Enterprise Management Consulting (Hangzhou) Co., Ltd. (“Kezhda”) signed an “Agreement on the Establishment of a Joint Venture” and set up a joint venture to carry out cell testing, cell drugs, intelligent microbiological testing and other related businesses. The registered capital of the joint venture is proposed to be RMB 30 million, of which the company invested 15.3 million yuan, accounting for the share
Gaode Investment, the majority shareholder of Tailin Biotech (300813.SZ), completed a reduction in holdings and reduced its holdings by a total of 521,900 shares
Tailin Biotech (300813.SZ) announced that the company's shareholder holding 5% or more of Gaode's investment holdings reduction plan has been implemented...
Tailin Biotech (300813.SZ): Won the overall asset transfer project involving the former Fusheng Electric Appliance Branch 2 with 136 million yuan
Gelonghui on December 19丨Tailin Biotech (300813.SZ) announced that on December 19, 2023, Zhejiang Tailin Medical Engineering Co., Ltd. (“Tailin Medical Engineering”), a wholly-owned subsidiary of the company, participated in the auction for the “Total Transfer of Assets Related to the Former Fusheng Electric Appliance Branch 2” project through a listing by Zhejiang Property Exchange Co., Ltd. The company won the “Total Transfer of Assets Involved in the Former Fusheng Electric Appliance Branch 2” project at a price of RMB 136.1 million, and received the “Notice of Signing” issued by Zhejiang Property Exchange Limited。 Tailin Medical Engineering will be with Hangzhou Fu in the future
Tailin Medical Engineering, a subsidiary of Tailin Biotech (300813.SZ), plans to participate in the auction for a plant in Hangzhou to implement a fund-raising project
Tailin Biology (300813.SZ) announced that Zhejiang Tailin Medical Engineering Co., Ltd., a wholly-owned subsidiary of the company (abbreviated as “...
Tailin Biology (300813.SZ): Plans to increase capital of Tailin Medical Engineering by 170 million yuan
Gelonghui (300813.SZ) announced that on December 12, Tailin Biotech (300813.SZ) announced that on December 12, 2023, the company held the 21st meeting of the third board of directors to deliberate and pass the “Bill on Using Raised Funds to Increase Capital to Wholly-owned Subsidiaries”, and agreed that the company would use the capital raised to increase capital by RMB 170 million to its wholly-owned subsidiary Zhejiang Tailin Medical Engineering Co., Ltd. (“Tailin Medical Engineering”), of which 50 million yuan was included in registered capital, 120 million yuan was included in capital reserves, and a special fund raising account was set up for the storage of the aforementioned funds. Use and administration. This capital increase
Tailin Biotech (300813.SZ): Recently obtained a total of 10 patent certificates
On December 4, Gelonghui (300813.SZ) announced that Zhejiang Tailin Life Science Co., Ltd. (“Tailin Life Science” for short) and Zhejiang Tailin Medical Engineering Co., Ltd. (“Tailin Medical Engineering”), a wholly-owned subsidiary of the company, have recently obtained a total of 10 patent certificates.
Tailin Biotech (300813.SZ): Hydrogen peroxide sterilization equipment can be used to fire bacteria in specific areas of space and surfaces of objects
Gelonghui, November 29丨Tailin Biotech (300813.SZ) said on the investor interactive platform that the company's hydrogen peroxide sterilization equipment can be used to sterilize specific spatial areas and object surfaces, and can be widely used in various places that require efficient, non-polluting killing of pathogenic microorganisms or control of microbial contamination. It is mainly used to disinfect confined spaces and sterile pharmaceutical equipment such as clean plants, biosafety cabinets, biosafety laboratories, medical facilities, and ambulances. Currently, it is not sold to the public.
Tailin Biotech (300813.SZ): No products directly used in the treatment of related respiratory diseases
Gelonghui November 16 | Tailin Biotech (300813.SZ) was surveyed by specific subjects on November 16, 2023. “Can the company's related products be used to treat this type of respiratory disease?” The company replied that the company has no products directly applied to the treatment of related respiratory diseases, but the company's vaporized hydrogen peroxide sterilization equipment can be used to sterilize specific spatial areas and object surfaces, and can be widely used in various places that require efficient and non-polluting killing of pathogenic microorganisms or control of microbial contamination.
Tailin Biotech (300813.SZ) released its first three quarter results, with net profit of RMB 21,312 million, a decrease of 54.90%
Tailin Biotech (300813.SZ) released its report for the third quarter of 2023, achieving revenue of 2.0 in the first three quarters...
No Data